GSK 2256294A

CAS: 1142090-23-0

Ref. 3D-SVB09023

Produktinformation

• Name: GSK 2256294A

Beschreibung

GSK 2256294A is a diazonium salt that is used to treat bowel diseases. It has been shown to inhibit the production of fatty acid metabolites, such as epoxyeicosatrienoic acids (EETs), and reduce the number of autophagy-positive cells in diabetic patients. This molecule also has cancer-fighting properties and can be used to treat various types of cancers, including colon cancer, breast cancer, and prostate cancer. GSK 2256294A is currently undergoing preclinical studies for treatment of inflammatory bowel disease, cardiovascular disease, and liver disease.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 447.46 g/mol
• Formel: C₂₁H₂₄F₃N₇O
• Reinheit: Min. 95%